Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

被引：2
|
作者：
Magnusson, Erik A.
Cao, Qing [1 ]
Linden, Michael A. [2 ]
Burns, Linda J.
Weisdorf, Daniel J.
Bachanova, Veronika
机构：
[1] Masonic Canc Ctr, Minneapolis, MN USA
[2] Univ Minnesota, Dept Pathol, Minneapolis, MN 55455 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3092.3092
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3092
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pre-transplant Hypogammaglobulinemia influences survival after allogeneic hematopoietic stem cell transplantation (AHSCT)
    Sobecks, Ronald
    Kalaycio, Matt
    Rybicki, Lisa
    Chan, Josephine
    Dean, Robert
    Sands, Karen
    Serafin, Mary
    Kosar, Jennifer
    Andresen, Steve
    Pohlman, Brad
    Copelan, Edward
    Bolwell, Brian
    BLOOD, 2007, 110 (11) : 589A - 589A
  • [22] Impact of Pre-Transplant Donor Renal Function on Graft Survival Following Kidney Transplantation.
    Irish, W.
    Corral, M.
    Ravindra, K.
    Sudan, D.
    Kreter, B.
    Hebden, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 425 - 425
  • [23] Rituximab Maintenance Therapy after Autologous Stem Cell Transplantation Improves Survival of Patients with Mantle Cell Lymphoma
    Graf, Solomon A.
    Stevenson, Philip A.
    Holmberg, Leona A.
    Till, Brian G.
    Press, Oliver W.
    Chauncey, Thomas R.
    Smith, Stephen D.
    Philip, Mary
    Orozco, Johnnie J.
    Shustov, Andrei R.
    Green, Damian J.
    Libby, Edward N.
    Bensinger, William I.
    Pagel, John M.
    Maloney, David G.
    Zhou, Yi
    Cassaday, Ryan D.
    Gopal, Ajay K.
    BLOOD, 2014, 124 (21)
  • [24] Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma
    Kasamon, YL
    Jones, RJ
    Diehl, LF
    Nayer, H
    Borowitz, MJ
    Garrett-Mayer, E
    Ambinder, RF
    Abrams, RA
    Zhang, Z
    Flinn, IW
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (01) : 39 - 46
  • [25] The Role of Pre-Transplant Induction Regimens and Autologous Stem Cell Transplantation in the Era of Novel Targeted Agents
    Gay, Francesca
    Cavallo, Federica
    Palumbo, Antonio
    DRUGS, 2015, 75 (04) : 367 - 375
  • [26] The Role of Pre-Transplant Induction Regimens and Autologous Stem Cell Transplantation in the Era of Novel Targeted Agents
    Francesca Gay
    Federica Cavallo
    Antonio Palumbo
    Drugs, 2015, 75 : 367 - 375
  • [27] Population-based study of patients with mantle cell lymphoma; era by era improvement in survival mediated by first-line rituximab and autologous stem cell transplantation
    Joshi, K.
    Hubbard, R.
    Bishton, M. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 94 - 94
  • [28] The impact of pre-transplant anemia on long-term survival following allogeneic bone marrow transplantation
    Xenocostas, A
    Wong, CJ
    Lazongas, C
    Sutton, DM
    Daly, A
    Kiss, TL
    Lipton, JH
    Messner, HA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 44 - 44
  • [29] Impact of Pre-Transplant Ruxolitinib in Myelofibrosis Patients on Outcome after Allogeneic Stem Cell Transplantation
    Abd Kadir, Sharifah Shahnaz Syed
    Zabelina, Tatjana
    Christopeit, Maximilian
    Wulf, Gerald G.
    Wagner, Eva Maria
    Bornhaeuser, Martin
    Schroeder, Thomas
    Crysandt, Martina
    Mayer, Karin
    Stelljes, Matthias
    Badbaran, Anita
    Wolschke, Christine
    Ayuk, Francis A.
    Triviai, Ioanna N.
    Wolf, Dominik
    Kroeger, Nicolaus
    BLOOD, 2016, 128 (22)
  • [30] Early autologous transplantation for mantle cell lymphoma may improve long term disease-free survival.
    Murali, S
    Lonial, S
    Redei, I
    Smith, K
    Waller, EK
    Heffner, LT
    Bucur, S
    Winton, E
    Manion, K
    Langston, A
    BLOOD, 2003, 102 (11) : 734A - 735A
12345